Study Finds Efficacy of Novel Prostate Cancer Molecular Imaging Drug

Study Finds Efficacy of Novel Prostate Cancer Molecular Imaging Drug
A recent study titled “99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer” published in The Journal of Nuclear Medicine, has assessed the potential of a novel drug to detect and visualize early prostate cancer in soft tissue, lymph nodes and bone. The research

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *